Search Results - "Nassif, E"

Effects of sodium glucose cotransporter type 2 inhibitors on heart failure by Nassif, Michael E., Kosiborod, Mikhail

“…Heart failure (HF) is emerging as one of the most common cardiovascular (CV) events in patients with type 2 diabetes (T2D), and the one associated with the…”
Get full text

Clinical outcomes associated with INTERMACS-defined right heart failure after left ventricular assist device implantation by LaRue, Shane J., MD, MPHS, Raymer, David S., MD, Pierce, Brian R., MD, Nassif, Michael E., MD, Sparrow, Christopher T., MD, Vader, Justin M., MD, MPHS

Get full text

Can we cure patients with abdominal Desmoplastic Small Round Cell Tumor? Results of a retrospective multicentric study on 100 patients by Honoré, C., Delhorme, J.B., Nassif, E., Faron, M., Ferron, G., Bompas, E., Glehen, O., Italiano, A., Bertucci, F., Orbach, D., Pocard, M., Quenet, F., Blay, J.Y., Carrere, S., Chevreau, C., Mir, O., Le Cesne, A.

“…Despite being associated with a very poor prognosis, long-term survivors across all series of Desmoplastic Small Round Cell Tumor (DSRCT) have been reported…”
Get full text

Systolic blood pressure on discharge after left ventricular assist device insertion is associated with subsequent stroke by Nassif, Michael E., MD, Tibrewala, Anjan, MD, Raymer, David S., MD, Andruska, Adam, MD, Novak, Eric, MS, Vader, Justin M., MD, MPHS, Itoh, Akinobu, MD, PhD, Silvestry, Scott C., MD, Ewald, Gregory A., MD, LaRue, Shane J., MD, MPHS

“…Background Stroke is a significant complication in patients supported with continuous-flow left ventricular assist devices (CF-LVAD) and hypertension is a…”
Get full text

Pre-Operative Right Ventricular Dysfunction Is Associated With Gastrointestinal Bleeding in Patients Supported With Continuous-Flow Left Ventricular Assist Devices by Sparrow, Christopher T., MD, Nassif, Michael E., MD, Raymer, David S., MD, Novak, Eric, MS, LaRue, Shane J., MD, MPHS, Schilling, Joel D., MD, PhD

“…Abstract Objectives This study sought to determine whether severe right ventricular (RV) dysfunction in the pre-operative setting is associated with an…”
Get full text

Adriamycin and ifosfamide-based regimen as induction chemotherapy in desmoplastic small round cell tumors: Results of a retrospective single-center study on 34 patients by Assi, T.S., Le Cesne, A., Nassif, E., Cavalcanti, A., Faron, M., Ibrahim, T., Le Pechoux, C., Mir, O., Adam, J., Dumont, S., Terrier, P., Honore, C.

Get full text

Can we cure patients with abdominal desmoplastic small round cell tumor? Results of a retrospective multicentric study on 100 patients by Delhorme, J.-B., Nassif, E., Ferron, G., Bompas, E., Adam, J., Glehen, O., Italiano, A., Bertucci, F., Orbach, D., Le Cesne, A., Blay, J.Y., Chevreau, C.M., Mir, O., Honoré, C.

Get full text

Global Outcome in Patients with Left Ventricular Assist Devices by Fendler, Timothy J., MD, MS, Nassif, Michael E., MD, Kennedy, Kevin F., MS, Joseph, Susan M., MD, Silvestry, Scott C., MD, Ewald, Gregory A., MD, LaRue, Shane J., MD, MPHS, Vader, Justin M., MD, MPHS, Spertus, John A., MD, MPH, Arnold, Suzanne V., MD, MHA

“…Abstract LVADs improve survival and quality of life (QOL) for most, but not all, patients with advanced heart failure. We described a broader definition of…”
Get full text

Screening Health Questionnaires and Patient-Reported Outcomes: Will Shortened Versions Overcome the Barriers to Their Implementation by Spertus, John A., MD, MPH, Nassif, Michael E., MD

Get full text

Association between sacubitril/valsartan initiation and real‐world health status trajectories over 18 months in heart failure with reduced ejection fraction by Thomas, Merrill, Khariton, Yevgeniy, Fonarow, Gregg C., Arnold, Suzanne V., Hill, Larry, Nassif, Michael E., Chan, Paul S., Butler, Javed, Thomas, Laine, DeVore, Adam D., Hernandez, Adrian F., Albert, Nancy M., Patterson, J. Herbert, Williams, Fredonia B., Spertus, John A.

“…Aims Improving the health status (symptoms, function, and quality of life) of patients with heart failure with reduced ejection fraction (HFrEF) is a primary…”
Get full text

Heterogeneity of health status treatment response with sacubitril/valsartan: insights from the CHAMP‐HF registry by Khariton, Yevgeniy, Fonarow, Gregg C., Hellkamp, Ann, Thomas, Laine, Nassif, Michael E., Butler, Javed, Duffy, Carol I., Albert, Nancy M., Spertus, John A.

“…Aims The aim of our study was to investigate heterogeneity of health status treatment response of sacubitril/valsartan in patients with heart failure with…”
Get full text

The Evolving Landscape of Heart Failure Treatment: A Dive Into Treatment Settings and Patient Outcomes by SANDESARA, UTTSAV, NASSIF, MICHAEL E.

Get full text

A Review of Cardiovascular Outcomes Trials of Glucose-Lowering Therapies and Their Effects on Heart Failure Outcomes by Nassif, Michael E., Kosiborod, Mikhail

“…Type 2 diabetes mellitus has long been recognized as a major risk factor for adverse atherosclerotic cardiovascular disease events; however, recent data…”
Get full text

The HeartMate Risk Score Identifies Patients With Similar Mortality Risk Across All INTERMACS Profiles in a Large Multicenter Analysis by Adamo, Luigi, MD, PhD, Tang, Yuanyuan, PhD, Nassif, Michael E., MD, Novak, Eric, MS, Jones, Philip G., MS, LaRue, Shane, MD, MPHS, Spertus, John A., MD, Mann, Douglas L., MD

“…Abstract Objectives This study sought to assess the performance of the HeartMate Risk Score (HMRS) in a large multicenter cohort, with a focus on its…”
Get full text

Early phase trials in soft-tissue sarcomas: clinical benefit of inclusion in early lines of treatment, molecular screening, and histology-driven trials by Nassif, E.F., Blay, J.-Y., Massard, C., Dufresne, A., Brahmi, M., Cassier, P., Ray-Coquard, I., Pautier, P., Leary, A., Sunyach, M.-P., Bahleda, R., Levy, A., Le Pechoux, C., Honoré, C., Mir, O., Le Cesne, A.

“…The prognosis of patients with advanced soft-tissue sarcomas (STS) remains dismal, and systemic therapeutic options are limited. Early phase trials are…”
Get full text

Empagliflozin Effects on Pulmonary Artery Pressure in Patients With Heart Failure: Results From the EMBRACE-HF Trial by Nassif, Michael E., Qintar, Mohammed, Windsor, Sheryl L., Jermyn, Rita, Shavelle, David M., Tang, Fengming, Lamba, Sumant, Bhatt, Kunjan, Brush, John, Civitello, Andrew, Gordon, Robert, Jonsson, Orvar, Lampert, Brent, Pelzel, Jamie, Kosiborod, Mikhail N.

“…Sodium glucose cotransporter 2 inhibitors (SGLT2 inhibitors) prevent heart failure (HF) hospitalizations in patients with type 2 diabetes and improve outcomes…”
Get full text

Are We Ready to Bell The Cat?: A Call for Cardiologists to Embrace Glucose-Lowering Therapies Proven to Improve Cardiovascular Outcomes by Nassif, Michael E, Kosiborod, Mikhail

Get full text

Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial by Biegus, Jan, Voors, Adriaan A, Collins, Sean P, Kosiborod, Mikhail N, Teerlink, John R, Angermann, Christiane E, Tromp, Jasper, Ferreira, Joao Pedro, Nassif, Michael E, Psotka, Mitchell A, Brueckmann, Martina, Salsali, Afshin, Blatchford, Jonathan P, Ponikowski, Piotr

“…Effective and safe decongestion remains a major goal for optimal management of patients with acute heart failure (AHF). The effects of the sodium-glucose…”
Get full text

Screening for BRCA1 and BRCA2 mutations among French-Canadian breast cancer cases attending an outpatient clinic in Montreal by Ghadirian, P, Robidoux, A, Nassif, E, Martin, G, Potvin, C, Patocskai, E, Younan, R, Larouche, N, Venne, A, Zhang, S, Royer, R, Narod, SA

“…Study subjects were French‐Canadian women with ductal carcinoma in situ (DCIS) or invasive breast cancer (incident or prevalent) who were treated and followed…”
Get full text

The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial by Nassif, Michael E., Windsor, Sheryl L., Borlaug, Barry A., Kitzman, Dalane W., Shah, Sanjiv J., Tang, Fengming, Khariton, Yevgeniy, Malik, Ali O., Khumri, Taiyeb, Umpierrez, Guillermo, Lamba, Sumant, Sharma, Kavita, Khan, Sadiya S., Chandra, Lokesh, Gordon, Robert A., Ryan, John J., Chaudhry, Sunit-Preet, Joseph, Susan M., Chow, Chen H., Kanwar, Manreet K., Pursley, Michael, Siraj, Elias S., Lewis, Gregory D., Clemson, Barry S., Fong, Michael, Kosiborod, Mikhail N.

“…Patients with heart failure and preserved ejection fraction (HFpEF) have a high burden of symptoms and functional limitations, and have a poor quality of life…”
Get full text